Cargando…

Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management

Chronic kidney disease (CKD) stages 3–5 now affects 8.5% of adults in the United Kingdom; with 4% of patients expected to reach stage 5 CKD. Increasing numbers of older patients are contributing to the growth of demand of kidney services. With the exception of transplantation, dialysis has been the...

Descripción completa

Detalles Bibliográficos
Autor principal: Johnston, Sheila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198114/
https://www.ncbi.nlm.nih.gov/pubmed/27669324
http://dx.doi.org/10.3390/healthcare4040072
_version_ 1782488828882190336
author Johnston, Sheila
author_facet Johnston, Sheila
author_sort Johnston, Sheila
collection PubMed
description Chronic kidney disease (CKD) stages 3–5 now affects 8.5% of adults in the United Kingdom; with 4% of patients expected to reach stage 5 CKD. Increasing numbers of older patients are contributing to the growth of demand of kidney services. With the exception of transplantation, dialysis has been the main form of renal replacement therapy (RRT) for advanced CKD. This elderly population is usually too frail and has many other co-existing medical complaints or co morbidities to undergo transplantation. Dialysis is an invasive treatment, and some frail elderly patients can experience many dialysis related symptoms. An alternative option for these patients is to choose conservative management (CM) of their stage 5 CKD. These patients often have complex supportive and palliative care needs. The frequency, severity and distress caused by symptoms related to stage 5 CKD are often under recognized and under treated. There is a need for early identification and management of symptoms as they present in patients with stage 5 CKD being managed conservatively. Symptom assessment should be focused on anticipating, identifying and alleviating any symptoms. This needs to be incorporated into the regular practice of those managing CM patients.
format Online
Article
Text
id pubmed-5198114
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-51981142017-01-04 Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management Johnston, Sheila Healthcare (Basel) Review Chronic kidney disease (CKD) stages 3–5 now affects 8.5% of adults in the United Kingdom; with 4% of patients expected to reach stage 5 CKD. Increasing numbers of older patients are contributing to the growth of demand of kidney services. With the exception of transplantation, dialysis has been the main form of renal replacement therapy (RRT) for advanced CKD. This elderly population is usually too frail and has many other co-existing medical complaints or co morbidities to undergo transplantation. Dialysis is an invasive treatment, and some frail elderly patients can experience many dialysis related symptoms. An alternative option for these patients is to choose conservative management (CM) of their stage 5 CKD. These patients often have complex supportive and palliative care needs. The frequency, severity and distress caused by symptoms related to stage 5 CKD are often under recognized and under treated. There is a need for early identification and management of symptoms as they present in patients with stage 5 CKD being managed conservatively. Symptom assessment should be focused on anticipating, identifying and alleviating any symptoms. This needs to be incorporated into the regular practice of those managing CM patients. MDPI 2016-09-22 /pmc/articles/PMC5198114/ /pubmed/27669324 http://dx.doi.org/10.3390/healthcare4040072 Text en © 2016 by the author; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Johnston, Sheila
Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
title Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
title_full Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
title_fullStr Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
title_full_unstemmed Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
title_short Symptom Management in Patients with Stage 5 CKD Opting for Conservative Management
title_sort symptom management in patients with stage 5 ckd opting for conservative management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198114/
https://www.ncbi.nlm.nih.gov/pubmed/27669324
http://dx.doi.org/10.3390/healthcare4040072
work_keys_str_mv AT johnstonsheila symptommanagementinpatientswithstage5ckdoptingforconservativemanagement